Clinical Trial

Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial

Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates a new digital health program that uses artificial intelligence (AI) to help patients lower their blood pressure through personalized lifestyle recommendations. The program collects information about patients' daily habits and blood pressure readings, then uses AI to suggest lifestyle changes that may work best for each person. The study will measure how well this program works across different groups of patients and aims to improve the program design to make it more effective and easier to use. The program will be offered to diverse patients at UC San Diego Health, including people of different ages, genders, races/ethnicities, and economic backgrounds, as part of their regular healthcare services.
Trial Details
NCT Number NCT07725250
Lead Sponsor National Bureau of Economic Research, Inc.
Collaborators: National Institute on Aging (NIA), University of California, San Diego
Conditions Hypertension
Enrollment 3,000 participants
Start Date 2026-04-10
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-24